.png?width=600&height=150&name=interpace%20(1).png)
Tuesday, February 10th, 1:00PM
Join Opentrons at Booth #912 at SLAS2026 in Boston, MA for an in-booth talk by Leah Ali Bishop (Assay Development, Interpace Diagnostics).
Talk title: Validating Automation Workflows In A Clinical Regulated Environment
Interpace Diagnostics®, LLC is a subsidiary of Interpace Biosciences and is a fully integrated commercial and bioinformatics company that provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services. Interpace Diagnostics develops and commercializes molecular diagnostic tests that deliver cutting-edge genetic and mutational analysis that help risk-stratify indeterminate thyroid nodules to help better inform treatment decisions.
Opentrons Labworks, Inc. accelerates research and healthcare innovation through an integrated lab automation platform. Its Flex® liquid-handling robots are accessible, AI-compatible, and easy to use, supporting open-source protocols. Opentrons empowers researchers worldwide by making advanced lab automation flexible, affordable, and widely accessible.
Leah Ali Bishop
Assay Development, Interpace Diagnostics
Subject to your consent given above, by clicking on "Register", Opentrons and Interpace may use your personal information to communicate with you for marketing purposes. All information you provide in this site will be governed by our Privacy Policy.